DH

Definitive Healthcare Corp
NASDAQHEALTHCAREHEALTH INFORMATION SERVICES

Key Statistics

Market Cap
$74.63M
P/E Ratio
EPS
$-1.75
Beta
1.33
52W High
$4.70
52W Low
$0.62
50-Day MA
$0.81
200-Day MA
$1.67
Dividend Yield
Profit Margin
-71.50%
Forward P/E
3.96
PEG Ratio

About Definitive Healthcare Corp

Definitive Healthcare Corp (DH) is a leading provider of comprehensive data and analytics solutions designed specifically for the healthcare industry, catering to a diverse clientele that includes pharmaceutical companies, payers, and healthcare providers. By harnessing extensive datasets and cutting-edge real-time analytics, Definitive Healthcare enhances operational efficiencies and delivers critical strategic insights, ultimately improving patient outcomes. With a strong commitment to innovation, the company is well-positioned to capitalize on the growing demand for sophisticated healthcare analytics, thereby establishing itself as a pivotal player in the transformation of healthcare delivery.

Official WebsiteUSAFY End: December

Fundamentals

Revenue (TTM)$238.26M
Gross Profit (TTM)$201.09M
EBITDA$37.11M
Operating Margin-8.65%
Return on Equity-75.50%
Return on Assets-1.74%
Revenue/Share (TTM)$2.28
Book Value$1.39
Price-to-Book0.49
Price-to-Sales (TTM)0.31
EV/Revenue0.264
EV/EBITDA46.69
Quarterly Earnings Growth (YoY)0.00%
Quarterly Revenue Growth (YoY)-5.50%
Shares Outstanding$105.52M
Float$35.97M
% Insiders3.71%
% Institutions86.54%

Historical Volatility

HV 10-Day
58.22%
HV 20-Day
94.96%
HV 30-Day
101.37%
HV 60-Day
86.06%
HV Rank
97.2%

Volatility is currently contracting

Analyst Ratings

Consensus ($2.20 target)
2
Buy
5
Hold
2
Strong Sell

Latest News

Definitive Healthcare Corp. reports inducement grants under Nasdaq Listing Rule 5635(c)(4)

FRAMINGHAM, Mass., July 27, 2026 (GLOBE NEWSWIRE) -- Definitive Healthcare (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that in connection with the hiring of one senior leader, the Human Capital Management and Compensation Committee (the “Committee”) of Definitive Healthcare's Board of Directors granted inducement awards. The Committee granted Srinivas Attipalli of the Company, Definitive Healthcare's new SVP and Head of AI & Data - Product, an inducement award consisting of 1,063,830 time-based restricted stock units (“RSUs”), effective July 24, 2026. These awards were individually negotiated and granted as an inducement material to Mr. Attipalli's respective commencement of employment with Definitive Healthcare in accordance with Nasdaq Listing Rule 5635(c)(4).

GlobeNewsWire7/27/2026Neutral
Definitive Healthcare advances data platform and integrations to deliver smarter healthcare insights

Latest enhancements provide deeper medical claims insights, a new integration with HubSpot®, seamless access to healthcare professional (HCP) data directly in Salesforce, and AI search capabilities Latest enhancements provide deeper medical claims insights, a new integration with HubSpot®, seamless access to healthcare professional (HCP) data directly in Salesforce, and AI search capabilities

GlobeNewsWire5/21/2026Neutral
Definitive Healthcare Reports Financial Results for First Quarter 2026

FRAMINGHAM, Mass., May 07, 2026 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare” or the “Company”) (Nasdaq: DH), an industry leader in healthcare market data and analytics, today announced financial results for the quarter ended March 31, 2026.

GlobeNewsWire5/7/2026Neutral
Definitive Healthcare Announces Timing of Its First Quarter 2026 Financial Results Conference Call and Webcast

FRAMINGHAM, Mass., April 23, 2026 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare”) (Nasdaq: DH), an industry leader in healthcare market data and analytics, today announced that it will report financial results for its first quarter ended March 31, 2026, on Thursday, May 7, 2026 after market close. The company will host a conference call and webcast at 5:00 PM (ET) / 2:00 PM (PT) to discuss the company's financial results.

GlobeNewsWire4/23/2026Neutral

Turn research into an automated options-selling system

Tiblio connects your broker and runs your put-and-call-writing strategy for you — on DH and any ticker you trade — then tracks every position and per-strategy win rate.

See how it works

More HEALTHCARE Stocks

Data last updated: 7/29/2026